Artrya (ASX:AYA) secured a three-year commercial agreement with Sonic Healthcare's (ASX:SHL) radiology division for the use of Salix Coronary Anatomy platform for coronary artery disease assessment at the point of care, according to a Wednesday Australian bourse filing.
The contract will generate revenue through a software-as-a-service subscription model and the first revenue is expected in the fiscal fourth quarter, the filing said.
Salix will be integrated into all Sonic Healthcare radiology centers that perform coronary computed tomography angiography scans for coronary heart disease detection, per the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.